1. Home
  2. APYX vs SGMT Comparison

APYX vs SGMT Comparison

Compare APYX & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

N/A

Current Price

$3.05

Market Cap

196.4M

Sector

Health Care

ML Signal

N/A

Logo Sagimet Biosciences Inc. Series A

SGMT

Sagimet Biosciences Inc. Series A

N/A

Current Price

$10.72

Market Cap

169.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
APYX
SGMT
Founded
1982
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.4M
169.4M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
APYX
SGMT
Price
$3.05
$10.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$6.50
$26.13
AVG Volume (30 Days)
144.1K
1.2M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
19.40
N/A
EPS
N/A
N/A
Revenue
N/A
$2,000,000.00
Revenue This Year
$11.93
N/A
Revenue Next Year
$11.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$4.50
52 Week High
$5.08
$11.24

Technical Indicators

Market Signals
Indicator
APYX
SGMT
Relative Strength Index (RSI) 36.73 62.62
Support Level $2.83 $9.95
Resistance Level $3.29 $11.15
Average True Range (ATR) 0.15 0.49
MACD 0.04 -0.05
Stochastic Oscillator 50.28 62.40

Price Performance

Historical Comparison
APYX
SGMT

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: